Skip to main content
. 2024 Mar 15;10(6):e28033. doi: 10.1016/j.heliyon.2024.e28033

Table 5.

Risk factors for mortality of patients.

Candidemia
Non-COVID-19
Candidemia COVID-19
Non-candidemia COVID-19
B P -value Exp(B) 95% CI B P -value Exp(B) 95% CI B P -value Exp(B) 95% CI
Age 0.203 0.346 1.225 0.804 1.867 0.214 0.466 1.238 0.697 2.200 0.516 0.016 1.675 1.099 2.553
Gender −0.295 0.173 0.745 0.487 1.138 0.222 0.429 1.249 0.720 2.166 0.240 0.235 1.271 0.856 1.887
SIRSa ≥ 2 10.963 0.999 57722.723 0.000 11.327 1.000 83022.238 0.000 0.723 0.018 2.060 1.129 3.757
Mechanical ventilation 1.572 0.009 4.818 1.487 15.612 1.572 0.009 4.818 1.487 15.612 4.990 0.000 147.000 28.957 746.239
Day of treatment for candidemia −0.275 0.017 0.760 0.606 0.953 −0.204 0.206 0.816 0.595 1.119 -
Charlson comorbidity index 0.165 0.025 1.179 1.021 1.362 0.040 0.763 1.041 0.804 1.347 0.344 0.003 1.411 1.124 1.771
Central venous catheterization 0.588 0.232 1.800 0.687 4.719 −0.260 0.755 0.771 0.151 3.929 1.277 0.003 3.587 1.542 8.349
Hypotension 1.961 0.002 7.104 2.061 24.490 2.217 0.001 9.178 2.391 35.226 3.595 0.001 36.414 4.658 284.660
a

SIRS, systemic inflammatory response syndrome.